{"id":2947,"date":"2026-08-26T09:38:47","date_gmt":"2026-08-26T08:38:47","guid":{"rendered":"https:\/\/officialcorepeptides.brandloom.net\/fr\/?post_type=product&p=2947"},"modified":"2026-08-26T09:38:47","modified_gmt":"2026-08-26T08:38:47","slug":"buy-selank-in-switzerland","status":"publish","type":"product","link":"https:\/\/officialcorepeptides.ch\/fr\/product\/buy-selank-in-switzerland\/","title":{"rendered":"Selank (10MG)"},"content":{"rendered":"

What Is Selank?<\/h2>\n

Selank is a synthetic heptapeptide with the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). It belongs to a class of peptide-based compounds developed as analogs of tuftsin a naturally occurring tetrapeptide (Thr-Lys-Pro-Arg) derived from the Fc fragment of immunoglobulin G (IgG) that plays a role in immune system regulation. Researchers originally developed Selank at the Institute of Molecular Genetics of the Russian Academy of Sciences as a synthetic analog of tuftsin with extended pharmacological properties.<\/p>\n

As a heptapeptide a peptide composed of seven amino acids Selank represents the tuftsin tetrapeptide extended at the C-terminus by a Pro-Gly-Pro sequence. This structural modification enhances the peptide’s stability and biological activity while preserving its immunomodulatory properties. For those looking to buy Selank in Switzerland<\/strong>, Core Peptides offers high-quality research-grade material for laboratory applications.<\/p>\n

Selank Research Overview<\/h2>\n

Selank has attracted significant research interest as a synthetic peptide with pronounced anxiolytic (anxiety-reducing) and nootropic (cognitive-enhancing) properties. Unlike traditional benzodiazepines, which act as direct agonists at GABA-A receptors, Selank functions as a positive allosteric modulator of GABAergic neurotransmission. This distinction may account for its reduced side-effect profile, as Selank does not produce sedation, dependence, or withdrawal symptoms typically associated with benzodiazepine-class compounds.<\/p>\n

Research interest in Selank centers on its multifaceted mechanism of action, which includes GABAergic modulation, enkephalinase inhibition, BDNF upregulation, and anti-inflammatory effects. Studies have demonstrated that Selank produces anxiolytic effects comparable to traditional benzodiazepines while also enhancing cognitive function and stress resilience. Consequently, Selank has generated significant interest as a research tool for investigating anxiety disorders, cognitive function, neuroplasticity, and stress-related conditions.<\/p>\n

When researchers choose to buy Selank in Switzerland<\/strong> for laboratory studies, they gain access to a compound that may help elucidate mechanisms of GABAergic signaling, neurotrophic factor regulation, and stress resilience at the molecular level.<\/p>\n

How Does Selank Work?<\/h2>\n

Selank exerts its biological effects through multiple interconnected mechanisms, including allosteric modulation of GABA-A receptors, inhibition of enkephalin-degrading enzymes, and regulation of neurotrophic factor expression.<\/p>\n

GABA-A Receptor Modulation<\/h3>\n

Selank’s primary anxiolytic mechanism involves positive allosteric modulation of GABA-A receptors. Unlike benzodiazepines, which bind to the benzodiazepine site on GABA-A receptors, Selank appears to act through a distinct allosteric binding site, modulating receptor function without directly activating the receptor. This mechanism enhances inhibitory GABAergic neurotransmission, producing anxiolytic effects without the sedation, tolerance, and dependence associated with benzodiazepines.<\/p>\n

Research has shown that Selank’s biological effects result from a combination of direct modulating action on target receptors and the initiation of biochemical cellular mechanisms that determine the molecular basis of the peptide’s physiological effects.<\/p>\n

Enkephalinase Inhibition<\/h3>\n

Selank also plays a critical role in the enkephalinergic system by inhibiting enkephalin-degrading enzymes. By slowing the breakdown of endogenous enkephalins, Selank increases the half-life of these natural anxiolytic peptides in the brain. This mechanism contributes to the peptide’s anxiolytic effects and may also influence pain modulation and stress responses.<\/p>\n

BDNF Upregulation and Neuroplasticity<\/h3>\n

A key component of Selank’s nootropic effects is its ability to increase Brain-Derived Neurotrophic Factor (BDNF) expression. Selank administration leads to higher levels of BDNF, which then binds to its high-affinity receptor, Tropomyosin receptor kinase B (TrkB). This activation triggers downstream events crucial for synaptic plasticity and memory consolidation.<\/p>\n

Furthermore, Selank modulates neurotransmitters such as serotonin and dopamine, which may contribute to its mood-stabilizing and cognitive-enhancing effects. The peptide’s influence on these monoamine systems, combined with its BDNF-elevating properties, supports its role in promoting neuroplasticity and stress resilience.<\/p>\n

Immunomodulatory and Anti-Inflammatory Effects<\/h3>\n

As a tuftsin analog, Selank retains immunomodulatory properties, including effects on antigen processing, presentation, and the complement system. Research has demonstrated that Selank mitigates ischemia-induced alterations in transcriptional activity, compensating for the effects of ischemia on gene expression. Studies have also shown that Selank affects intestinal microbiota and colon wall condition in stressed animal models.<\/p>\n

Researchers who buy Selank in Switzerland<\/strong> for research purposes can investigate these mechanisms across diverse experimental models of anxiety, cognition, neuroplasticity, and stress resilience.<\/p>\n

Why Is Selank Studied?<\/h2>\n

Researchers study Selank primarily for its potential relevance to anxiety disorders, cognitive enhancement, and neuroplasticity. The peptide’s ability to modulate GABAergic transmission, inhibit enkephalin degradation, and upregulate BDNF expression makes it a valuable tool for understanding the molecular basis of anxiety, learning, memory, and stress resilience.<\/p>\n

The peptide’s connection to the tuftsin immunomodulatory system has made it a focus of neuroimmunology research. Preclinical studies have explored Selank’s effects on anxiety-related behaviors, cognitive function, and stress responses in various experimental models, including rodent behavioral paradigms and transcriptomic analyses.<\/p>\n

Moreover, researchers study Selank in the context of neuroprotection and recovery from neurological insults. Transcriptomic studies have shown that Selank acts at the molecular genetic level to regulate processes triggered by cerebral ischemia, including neural pulse transmission and immunity. The peptide’s anti-inflammatory and neurotrophic properties may offer insights into mechanisms of neural repair and recovery.<\/p>\n

Researchers who buy Selank in Switzerland<\/strong> from Core Peptides can incorporate this peptide into their studies on anxiety, cognition, neuroplasticity, neuroimmunology, and stress-related conditions.<\/p>\n

Selank Research Areas<\/h2>\n\n\n\n\n\n\n\n\n\n\n\n\n
Research Area<\/th>\nDescription<\/th>\n<\/tr>\n<\/thead>\n
Anxiolytic Research<\/strong><\/td>\nInvestigating Selank’s anxiety-reducing effects via GABA-A receptor modulation<\/td>\n<\/tr>\n
Cognitive Enhancement<\/strong><\/td>\nStudying Selank’s nootropic effects on learning, memory, and cognitive performance<\/td>\n<\/tr>\n
Neuroplasticity<\/strong><\/td>\nExamining Selank’s BDNF upregulation and effects on synaptic plasticity<\/td>\n<\/tr>\n
Enkephalinase Inhibition<\/strong><\/td>\nExploring Selank’s inhibition of enkephalin-degrading enzymes<\/td>\n<\/tr>\n
Neuroimmunology<\/strong><\/td>\nInvestigating Selank’s immunomodulatory and anti-inflammatory properties<\/td>\n<\/tr>\n
Stress Resilience<\/strong><\/td>\nPreclinical research into Selank’s effects on stress responses and coping mechanisms<\/td>\n<\/tr>\n
Neuroprotection<\/strong><\/td>\nStudying Selank’s protective effects in models of cerebral ischemia and neural injury<\/td>\n<\/tr>\n
Serotonin & Dopamine Modulation<\/strong><\/td>\nExploring Selank’s effects on monoamine neurotransmitter systems<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Scientific Research on Selank<\/h2>\n

Researchers have conducted scientific studies on Selank in both in vitro and in vivo settings, deriving evidence from cell cultures, rodent models, and human clinical research. The peptide originates from the tuftsin analog research program at the Institute of Molecular Genetics of the Russian Academy of Sciences.<\/p>\n

In Vitro Evidence<\/h3>\n

In vitro studies have demonstrated that Selank acts as a positive allosteric modulator of GABA-A receptors, enhancing inhibitory neurotransmission without directly activating the receptor. The peptide also inhibits enkephalin-degrading enzymes, increasing the half-life of endogenous enkephalins.<\/p>\n

Research has shown that Selank’s biological effects result from a combination of direct modulating action on target receptors and the initiation of biochemical cellular mechanisms that determine the molecular basis of the peptide’s physiological effects.<\/p>\n

Preclinical Animal Studies<\/h3>\n

In rodent models, researchers have investigated Selank’s effects on behavior and neurochemical processes. Studies have demonstrated that Selank at a dose of 100 \u03bcg\/kg produced an anxiolytic effect in the open-field test and increased the half-life of plasma leu-enkephalin in BALB\/c mice. Research has also shown that Selank recovers learning and memory in animal models.<\/p>\n

Transcriptomic studies have revealed that Selank acts at the molecular genetic level to regulate processes triggered by cerebral ischemia, including neural pulse transmission and immunity. The peptide has been shown to mitigate ischemia-induced alterations in transcriptional activity, compensating for the effects of ischemia on gene expression. Selank was found to be active towards genes involved in neural pulse transmission and immunity, including antigen processing and presentation and the complement system.<\/p>\n

Furthermore, studies have examined Selank’s effects on intestinal microbiota and colon wall condition in Wistar male rats subjected to restraint stress, demonstrating the peptide’s impact on the gut-brain axis.<\/p>\n

Human Research<\/h3>\n

Selank has been studied in human clinical research and has entered clinical practice in Russia as an anxiolytic agent with stimulating, nootropic, and emotional-normalizing effects. The peptide’s anxiolytic efficacy is reported to be comparable to that of traditional benzodiazepines, but with minimal side effects and no sedation or dependence.<\/p>\n

Functional connectomic studies have assessed the effects of Selank and the related nootropic peptide Semax on whole-brain resting-state functional connectivity in healthy participants. These studies provide insights into the neural networks modulated by Selank administration.<\/p>\n

Nevertheless, researchers should note that while Selank has been used clinically in Russia, the peptide is supplied for laboratory research purposes only. Scientists who buy Selank in Switzerland<\/strong> should remain aware of these evidence considerations.<\/p>\n

Selank Compared With Related Peptides<\/h2>\n\n\n\n\n\n\n\n\n\n
Peptide<\/th>\nRelationship to Selank<\/th>\nKey Differences<\/th>\n<\/tr>\n<\/thead>\n
Tuftsin<\/strong><\/td>\nParent compound; Selank is a tuftsin analog<\/td>\nTuftsin is a tetrapeptide (Thr-Lys-Pro-Arg); Selank is a heptapeptide with C-terminal Pro-Gly-Pro extension for enhanced stability<\/td>\n<\/tr>\n
Semax<\/strong><\/td>\nDeveloped alongside Selank; both are Russian nootropic peptides<\/td>\nSemax is an ACTH(4-10) analog with different mechanism; Selank is a tuftsin analog targeting GABAergic system<\/td>\n<\/tr>\n
Afobazole<\/strong><\/td>\nBoth studied for anxiolytic effects<\/td>\nAfobazole is a non-peptide anxiolytic; Selank is a peptide with additional nootropic properties<\/td>\n<\/tr>\n
Benzodiazepines<\/strong><\/td>\nBoth produce anxiolytic effects<\/td>\nBenzodiazepines are direct GABA-A agonists with sedation and dependence; Selank is a positive allosteric modulator with minimal side effects<\/td>\n<\/tr>\n
Noopept<\/strong><\/td>\nBoth studied for cognitive enhancement<\/td>\nNoopept is a dipeptide with different mechanism; Selank combines anxiolytic and nootropic effects<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Research Applications<\/h2>\n

Researchers utilize Selank in a variety of laboratory research applications, primarily in the fields of neuroscience, psychopharmacology, and neuroimmunology. Key research applications include:<\/p>\n